Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 9/20 | 0.44 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 5/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6558334 | 0.98 | FDPS (0.45) | FDPSSMPD1SPHK1GGPS1 | |
| SCHEMBL7752435 | 0.89 | FDPS (0.41) | FDPSSMPD1SPHK1 | |
| Hydrochloric Acid SCHEMBL5604440 | 0.84 | FDPS (0.45) | FDPSSMPD1SPHK1GGPS1DNM1 | |
| Hydrochloric Acid SCHEMBL4443834 | 0.83 | FDPS (0.44) | FDPSSMPD1SPHK1GGPS1DNM1 | |
| Hydrochloric Acid SCHEMBL16468331 | 0.83 | FDPS (0.44) | FDPSSMPD1SPHK1GGPS1DNM1 | |
| SCHEMBL4448029 | 0.82 | FDPS (0.47) | FDPSSMPD1SPHK1GGPS1 | |
| SCHEMBL3676595 | 0.80 | FDPS (0.45) | FDPSSMPD1SPHK1GGPS1 | |
| SCHEMBL123833 | 0.80 | FDPS (0.45) | FDPSSMPD1SPHK1GGPS1 | |
| Bromide SCHEMBL28893997 | 0.80 | FDPS (0.45) | FDPSSMPD1SPHK1GGPS1DNM1 | |
| SCHEMBL3677155 | 0.80 | FDPS (0.45) | FDPSSMPD1SPHK1GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040071653-A1 | Antimicrobial ternary surfactant blend comprising cationic, anionic, and bridging surfactants, and methods of preparing same | STEPAN COMPANY | 2004-04-15 | — | — | US | disclosed |
| EP-1324821-A2 | EMULSION COMPRISING A BLEND OF CATIONIC, ANIONIC AND BRIDGING SURFACTANS, OIL AND WATER | STEPAN COMPANY (US) | 2003-07-09 | — | — | EP | disclosed |
| EP-1320354-A2 | SHAMPOO AND BODY WASH COMPOSITION | STEPAN COMPANY (US) | 2003-06-25 | — | — | EP | disclosed |
| EP-1318720-A2 | ANTIMICROBIAL TERNARY SURFACTANT BLEND COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS, AND METHODS OF PREPARING SAME | STEPAN COMPANY (US) | 2003-06-18 | — | — | EP | disclosed |
| US-6528070-B1 | Emulsification system comprising a mixture of at least one cationic surfactant, at least one anionic surfactant, at least one \"bridging surfactant\", an oil and water, along with methods for preparing such emulsions. Synergistic mixtures of | STEPAN COMPANY | 2003-03-04 | — | — | US | disclosed |
| EP-1257350-A1 | TERNARY SURFACTANT BLENDS COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS AND METHODS OF PREPARING SAME | STEPAN COMPANY (US) | 2002-11-20 | — | — | EP | disclosed |
| WO-2002022083-A2 | EMULSION COMPRISING A BLEND OF CATIONIC, ANIONIC AND BRIDGING SURFACTANTS, OIL AND WATER | STEPAN COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| WO-2002021916-A2 | ANTIMICROBIAL TERNARY SURFACTANT BLEND COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS, AND METHODS OF PREPARING SAME | STEPAN COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| WO-2002022105-A2 | SHAMPOO AND BODY WASH COMPOSITION | STEPAN COMPANY (US) | 2002-03-21 | — | — | WO | disclosed |
| US-6306805-B1 | Shampoo and body wash composition comprising ternary surfactant blends of cationic, anionic, and bridging surfactants and methods of preparing same | STEPAN COMPANY | 2001-10-23 | — | — | US | disclosed |
| WO-2001019507-A1 | TERNARY SURFACTANT BLENDS COMPRISING CATIONIC, ANIONIC, AND BRIDGING SURFACTANTS AND METHODS OF PREPARING SAME | STEPAN COMPANY (US) | 2001-03-22 | — | — | WO | disclosed |
| US-5472455-A | Water soluble complexes for removing oily stains from fabrics | COLGATE PALMOLIVE CO. (US) | 1995-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040071653-A1 | Antimicrobial ternary surfactant blend comprising cationic, anionic, and bridging surfactants, and methods of preparing same | ARG1, SEPTIN7, NRDC | FDPS 2218/4885SMPD1 276/4885SPHK1 2934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.